Glaukos officer proposes $249K share sale
The proposed shares are attributed to restricted stock vesting, and three earlier sales by the officer are also reported.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GLAUKOS Corp (GKOS) officer Tomas Navratil reported a proposed sale of 1,615 common shares, with an aggregate market value of $249,157.98 and an approximate sale date of September 25, 2026. Fidelity Brokerage Services LLC is listed as broker, with NYSE as the exchange. Restricted stock vesting on March 22, 2025, is listed as the shares’ source. Earlier reported sales were 716 shares on July 1, 2026, 13,744 shares on August 28, 2026, and 1,457 shares on September 16, 2026.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.